Literature DB >> 8144865

Organ-specific autoimmunity in patients with premature ovarian failure.

L Belvisi1, F Bombelli, L Sironi, N Doldi.   

Abstract

The diagnosis of premature ovarian failure (POF) was made in 45 women (aged 14 to 39 yr) with high concentrations of FSH and LH. Sera from these patients and a control group of 28 women were used to detect organ-specific autoantibodies. Eighteen patients with POF (40%) were positive for at least one autoantibody. In the control group only one woman (3.6%) showed autoimmunity. Antithyroid was the most representative autoimmunity (20%) in the POF group. By indirect immunofluorescence, only one patient was positive for antiovarian and antiadrenal antibodies. In summary, the results of this study are consistent with previous immunohistochemical data which indicate that autoimmune disorders are common in patients with POF. Furthermore, the detection of antiovarian antibodies in only one patient confirms that they are probably detectable in a short period of the disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8144865     DOI: 10.1007/BF03348951

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  19 in total

1.  Autoimmunity and ovarian failure.

Authors:  M de Moraes Ruehsen; R M Blizzard; R Garcia-Bunuel; G S Jones
Journal:  Am J Obstet Gynecol       Date:  1972-03       Impact factor: 8.661

2.  Gonadotropins in women with amenorrhea. The use of plasma follicle-stimulating hormone to differentiate women with and without ovarian follicles.

Authors:  R L Goldenberg; J M Grodin; D Rodbard; G T Ross
Journal:  Am J Obstet Gynecol       Date:  1973-08-01       Impact factor: 8.661

3.  Premature ovarian failure: evidence for the autoimmune mechanism.

Authors:  C B Coulam; R D Kempers; R V Randall
Journal:  Fertil Steril       Date:  1981-08       Impact factor: 7.329

4.  Tissue antibodies in malignant and benign urogenital disease.

Authors:  R Kurki; E Linder; A Miettinen; O Alfthan; A Heikkinen; A Pasternack
Journal:  Int J Cancer       Date:  1977-03-15       Impact factor: 7.396

5.  Premature ovarian failure: its relationship to autoimmune disease.

Authors:  M M Alper; P R Garner
Journal:  Obstet Gynecol       Date:  1985-07       Impact factor: 7.661

6.  Premature menopause. I. Etiology.

Authors:  C B Coulam; R J Ryan
Journal:  Am J Obstet Gynecol       Date:  1979-03-15       Impact factor: 8.661

7.  Premature ovarian failure.

Authors:  J Aiman; C Smentek
Journal:  Obstet Gynecol       Date:  1985-07       Impact factor: 7.661

8.  The prevalence of autoimmune disorders among patients with primary ovarian failure.

Authors:  C B Coulam
Journal:  Am J Reprod Immunol       Date:  1983-09       Impact factor: 3.886

9.  Prevalence of circulating antibodies directed toward ovaries among women with premature ovarian failure.

Authors:  C B Coulam; R J Ryan
Journal:  Am J Reprod Immunol Microbiol       Date:  1985-09

10.  Spontaneous pregnancy in a patient with hypergonadotrophic ovarian failure.

Authors:  C S Wright; H S Jacobs
Journal:  Br J Obstet Gynaecol       Date:  1979-05
View more
  3 in total

1.  Ovarian antibodies as detected by indirect immunofluorescence are unreliable in the diagnosis of autoimmune premature ovarian failure: a controlled evaluation.

Authors:  Judy A Novosad; Sophia N Kalantaridou; Zhi-Bin Tong; Lawrence M Nelson
Journal:  BMC Womens Health       Date:  2003-03-17       Impact factor: 2.809

Review 2.  Effect of hypothyroidism and thyroid autoimmunity on the ovarian reserve: A systematic review and meta-analysis.

Authors:  Yuko Hasegawa; Yoshikazu Kitahara; Satoko Osuka; Yumiko Tsukui; Mio Kobayashi; Akira Iwase
Journal:  Reprod Med Biol       Date:  2021-12-07

3.  A retrospective study on IVF outcome in euthyroid patients with anti-thyroid antibodies: effects of levothyroxine, acetyl-salicylic acid and prednisolone adjuvant treatments.

Authors:  Alberto Revelli; Simona Casano; Luisa Delle Piane; Giuseppina Grassi; Gianluca Gennarelli; Daniela Guidetti; Marco Massobrio
Journal:  Reprod Biol Endocrinol       Date:  2009-11-27       Impact factor: 5.211

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.